Clinical Trials in Philadelphia

Showing 2261-2280 of 9,968 trials

A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis

NCT05757856

An open-label phase 2 study to assess the safety and exploratory diagnostic performance of the oral radiopharmaceutical agent NDX-3315 and NDX-3324 in healthy participants and patients with eosinophilic esophagitis (EoE).

Eosinophilic Esophagitis

NexEos Diagnostics, Inc.34 participantsStarted Jan 2023

Chicago, Illinois, United States • Philadelphia, Pennsylvania, United States • Salt Lake City, Utah, United States

RECRUITINGNA< 1 mile

Driver Education Research Study

NCT06413927

This study will test the effectiveness of different types of driver training interventions for reducing young new driver crash risk early after licensure.

Risk Reduction BehaviorInjuriesAccident, Traffic+1 more

Children's Hospital of Philadelphia1,300 participantsStarted Aug 2024

Philadelphia, Pennsylvania, United States

A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis

Driver Education Research Study

Find Trials by Condition in Philadelphia

Improving Sleep in the Neurology In-Patient Population

tACS to Enhance Language Abilities

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

[18F]FES PET/CT in Endocrine Refractory Breast Cancer

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

EXACERBATIONS AND REAL-WORLD OUTOMES INCLUDING CARDIOPULMONARY EVENTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (MITOS: EROS+CP US Study)

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

HPV Vaccine Confident Families

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries

A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)